Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2755869 | 0.79 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2LMNAALOX15HTT | |
| SCHEMBL13870640 | 0.75 | HTT (0.61) | ALDH1A1SMN1; SMN2LMNAALOX15HTT | |
| SCHEMBL17029122 | 0.74 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2LMNAALOX15ROCK2 | |
| SCHEMBL2631530 | 0.74 | HTT (0.53) | ALDH1A1SMN1; SMN2LMNAALOX15HTT | |
| SCHEMBL1587967 | 0.73 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2LMNAALOX15ROCK2 | |
| SCHEMBL4905769 | 0.71 | HTT (0.57) | ALDH1A1SMN1; SMN2LMNAALOX15HTT | |
| SCHEMBL13060078 | 0.71 | SMN1; SMN2 (0.64) | ALDH1A1SMN1; SMN2LMNAALOX15ROCK2 | |
| SCHEMBL1587633 | 0.71 | ALDH1A1 (0.58) | ALDH1A1SMN1; SMN2LMNAALOX15ROCK2 | |
| SCHEMBL17092054 | 0.71 | HPGDS (0.47) | ALDH1A1SMN1; SMN2KDM4EHPGDTSHR | |
| SCHEMBL12529458 | 0.70 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2LMNAALOX15ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10035790-B2 | RORγ modulators | EXELIXIS, INC. (US) | 2018-07-31 | — | — | US | disclosed |
| US-20150266856-A1 | RORGamma Modulators | EXELIXIS, INC. | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150266856-A1 | RORGamma Modulators | RORB, RORA, RORC | ALDH1A1 1877/4885SMN1; SMN2 3767/4885LMNA 2685/4885 |
| US-10035790-B2 | RORγ modulators | RORB, RORA, RORC | ALDH1A1 1669/4885SMN1; SMN2 3896/4885LMNA 2906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.